See related research by Pradelli *et al*., <http://ccforum.com/content/16/5/R184>

Correction
==========

Following publication of their article \[[@B1]\], the authors noticed that Table [2](#T1){ref-type="table"} should list medium chain triglycerides (MCT) instead of olive oil emulsion (OO) in the column \'Standard lipid emulsion\' as follows;

###### 

Studies evaluating n-3 PUFA-enriched lipid emulsions for parenteral nutrition and reported outcomes/measured parameters

  Study                                               Setting (n)                                           n-3 PUFA-enriched lipid emulsion   Standard lipid emulsion   Clinical outcomes                                     Laboratory outcomes
  --------------------------------------------------- ----------------------------------------------------- ---------------------------------- ------------------------- ----------------------------------------------------- ------------------------------------------------------------------------
  **ICU patients^a^(*n*= 762)**                                                                                                                                                                                                
  Antebi 2004 \[6\]                                   Major surgery (20)                                    SO/MCT/OO/FO^b^                    SO                                                                              AST^c^, ALT^c^, CRP, alpha-T, TG^c^
  Barbosa 2010 \[7\]                                  Sepsis (23)                                           SO/MCT/n-3 TGs^d^                  SO/MCT                    H LOS, ICU LOS, Mortality                             CRP, EPA, DHA, AA, LTB4, AST, ALT, Bilirubin, OI, IL-6, PTT, Lac
  Berger 2008 \[8\]                                   Abdominal aortic aneurysm (24)                        SO/MCT/n-3 TGs^d^                  SO/MCT                    Mortality, H LOS, ICU LOS                             EPA, DHA, AA, alpha-T, CRP, TG
  Friesecke 2008 \[9\]                                Critical medical (165)                                SO + FO^e^                         SO/MCT                    Mortality, Infection rate, ICU LOS, Bleeding events   IL-6^f^TBU
  Heller 2004 \[10\]                                  Elective colorectal (44)                              SO + FO^e^                         SO                        ICU LOS                                               AST, ALT, CRP, Bilirubin, PT (Quick), PTT, TBU
  Morlion 1996 \[11\]                                 Gastric carcinoma (20)                                SO + FO^e^                         SO                                                                              AA, EPA, DHA, LTB5, LTB4
  Piper 2009 \[12\]                                   Major abdominal or craniomaxillofacial surgery (44)   SO/MCT/OO/FO^b^                    SO/OO                                                                           AST, ALT, TG
  Roulet 1997 \[13\]                                  Elective oesophagectomy (19)                          SO + FO^e^                         SO                                                                              EPA, DHA, AA, BT
  Sabater 2011 \[14\]                                 Acute respiratory distress syndrome (44)              SO/MCT/n-3 TGs^d^                  SO                        Mortality                                             LTB4
  Wachtler 1997 \[15\]                                Elective abdominal surgery (40)                       SO/MCT/n-3 TGs^d^                  SO/MCT                    Infection rate, H LOS, ICU LOS                        LTB4, LTB5, LTB ratio, IL-6^f^
  Wang 2008 \[16\]                                    Severe acute pancreatitis (40)                        SO + FO^e^                         SO                        Mortality, Infection rate, H LOS, ICU LOS             EPA, CRP, OI
  Weiss 2002 \[17\]                                   Gastrointestinal surgery (23)                         SO + FO^e^                         SO                        Mortality, Infection rate, H LOS, ICU LOS             IL-6^g^
  Wichmann 2007 \[18\]                                Major intestinal surgery (256)                        SO/MCT/n-3 TGs^d^                  SO                        Mortality, Infection rate, H LOS, ICU LOS             AST, Bilirubin, TG, CRP, LTB5, LTB ratio, alpha-T, EPA, PT (Quick), Cr
  **Elective surgery, non-ICU patients (*n*= 740)**                                                                                                                                                                            
  Badia-Tahull 2010 \[19\]                            Major gastrointestinal surgery (27)                   SO + FO^e^                         SO/OO                     Mortality, H LOS, Infection rate                      ALT, CRP, TBU, Cr, PlU
  Grimm 2006 \[20\]                                   Radical colorectal cancer resection (33)              SO/MCT/OO/FO^b^                    SO                        H LOSc                                                alpha-T, AA, EPA, DHA, LTB4, LTB5, LTB ratio
  Jiang 2010 \[21\]                                   Gastrointestinal malignancy (203)                     SO + FO^e^                         SO                        H LOS, Infection rate, Bleeding events                IL-6, CrCl
  Klek 2005 \[22\]                                    Major abdominal surgery (58)                          SO + FO^e^                         SO/MCT                    H LOS, Infection rate                                 ALT, AST, Cr, PlU
  Koeller 2003 \[23\]                                 Major abdominal surgery (30)                          SO/MCT/n-3 TGs^d^                  SO                                                                              LTB4, LTB5, LTB ratio
  Liang 2008 \[24\]                                   Colorectal cancer (41)                                SO + FO^e^                         SO                        Mortality, Infection rate, H LOS                      IL-6
  Linseisen 2000 \[25\]                               Major abdominal surgery (33)                          SO/MCT/n-3 TGs^cd^                 SO                                                                              alpha-T, AA, EPA, DHA
  Makay 2011 \[26\]                                   Major gastric surgery (26)                            SO + FO^e^                         SO                        Mortality, Infection rate, H LOS                      AST, ALT, Cr, PlU; Lac
  Mertes 2006 \[27\]                                  Abdominal surgery (249)                               SO/MCT/OO/FO^b^                    SO                        Mortality, H LOS                                      AST, ALT, TG, Bilirubin
  Senkal 2007 \[28\]                                  Major abdominal cancer (40)                           SO/MCT/n-3 TGs^d^                  SO/MCT                    Infection rate                                        AA, EPA, DHA

^a^Allocation to the ICU subgroup was driven by explicit mention in the published paper of an ICU stay, in the Methods or Results sections of the original article. ^b^SMOFlipid 20% (Fresenius Kabi): 1000 ml of emulsion contains: soya-bean oil, refined 60.0 g, triglycerides, medium-chain, 60.0 g, olive oil, refined 50.0 g, FO, rich in n-3-acids 30.0 g. ^c^Not used for meta-analysis as data are from a subgroup of Mertes *et al*. \[27\]. ^d^Lipoplus 20% (B.Braun): 1000 ml of emulsion contains: medium-chain triglycerides: 100.0 g, soybean oil, refined: 80.0 g, N-3-acid triglycerides: 20.0 g. ^e^Omegaven 10% fish oil emulsion (Fresenius Kabi): 100 ml emulsion contains highly refined fish oil 10.0 g containing eicosapentaenoic acid (EPA) 1.25 to 2.82 g, docosahexaenoic acid (DHA) 1.44 to 3.09 g, dl-α-tocopherol (as antioxidant) 0.015 to 0.0296 g. ^f^Data reported by graph only or qualitatively. ^g^No SD reported. AA, (%) content of arachidonic acid in serum/cellular membranes; alpha-T, alpha-tocopherol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BT, bleeding time; Cr, serum creatinine; CrCl, creatinine clearance; CRP, C-reactive protein; DHA,(%) docosahexaenoic acid content in serum/cellular membranes; EPA, (%) eicosapentaenoic acid content in serum/cellular membranes; FO, fish oil emulsion; Lac, lactate; (H) LOS, (Hospital) length of stay; ICU, intensive care unit; LTB, leukotriene B; LTB ratio, LTB5: LTB4; (n-3) TGs, (n-3) triglycerides; MCT, medium chain triglycerides; OI, oxygenation index; OO, olive oil emulsion; PlU, serum urea; PT, prothrombin time; PTT, partial thromboplastin time; SO, soybean oil emulsion; TBU, transfused blood units.

\- For the study Barbosa 2010 \[7\], this column should read SO/MCT

\- For the study Berger 2008 \[8\], this column should read SO/MCT

\- For the study Friesecke 2008 \[9\], this column should read SO/MCT

\- For the study Wachtler 1997 \[15\], this column should read SO/MCT

\- For the study Klek 2005 \[22\], this column should read SO/MCT

\- For the study Senkal 2007 \[28\], this column should read SO/MCT

The correct version of the table appears overleaf.
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